Tobacco companies' interests in smokeless tobacco products in Europe are driven by profit not health

September 10, 2013

Transnational tobacco companies' investments in smokeless tobacco products, such as snus (a moist tobacco product that is placed under the upper lip), in Europe are not due to a concern for the health impacts of smoking but are instead driven purely by business interests according to new research by Silvy Peeters and Anna Gilmore from the University of Bath UK and the UK Centre for Tobacco Control Studies, published this week in PLOS Medicine.

To inform the policy debate surrounding snus, which is banned from sale in the European Union (EU) under legislation that is currently being reviewed in Brussels, the researchers analysed internal tobacco industry documents that have been made available by litigation alongside contemporary industry documentation to examine the historical interests of transnational tobacco companies. The analysis reveals tobacco companies' efforts to enter the EU market, and influence national and EU . The researchers also compare the industry's privately documented interests (observed via internal documents and investor presentations) with those harm reduction pursuits it has publicly espoused, and explore the implications for EU tobacco control policy.

Although the analysis was limited by the extent of the documents available to the researchers, the authors say, "[t]here is clear evidence that [British American Tobacco]'s early interest in introducing [] in Europe was based on the potential for creating an alternative form of in light of declining and social restrictions on smoking, with young people a key target."

The authors note, "[the study's findings] indicate that the industry's rhetoric on harm reduction has been inconsistent with historical and recent documents and business actions. Instead, the findings suggest that the [transnational tobacco companies'] interest in reduced-risk products lies in maintaining the status quo in favour of cigarettes for as long as possible while simultaneously providing a longer-term source of profit should the cigarette model prove unsustainable; the reputational benefits are an additional asset."

The authors conclude, "by investing in snus, and recently nicotine, [transnational tobacco companies] have eliminated competition between cigarettes and lower-risk products, thus helping maintain the current market balance in favour of (highly profitable) cigarettes while ensuring [transnational '] long-term future should cigarette sales decline further and profit margins be eroded."

Explore further: Smokeless tobacco sold illegally online, UK researchers find

More information: Peeters S, Gilmore AB (2013) Transnational Tobacco Company Interests in Smokeless Tobacco in Europe: Analysis of Internal Industry Documents and Contemporary Industry Materials. PLoS Med 10(9): e1001506. DOI: 10.1371/journal.pmed.1001506

Related Stories

Tobacco companies are not public health stakeholders

May 28, 2013

When assessing information presented by the tobacco industry, the US regulator, the Food and Drug Administration (FDA) and regulatory bodies in other countries, should be aware that they are dealing with companies with a ...

FDA allows two new cigarettes to hit market

June 25, 2013

(HealthDay)—Using its newfound authority to regulate tobacco, the U.S. Food and Drug Administration has for the first time allowed two new cigarette brands to hit the market.

Recommended for you

Children born in the summer more likely to be healthy adults

October 12, 2015

Women who were born in the summer are more likely to be healthy adults, suggests new research published in the journal Heliyon. The authors of the study, which involved almost half a million people in the UK, say more sunlight ...

Mobile app records our erratic eating habits

September 24, 2015

Breakfast, lunch, and dinner? For too many of us, the three meals of the day go more like: office meeting pastry, mid-afternoon energy drink, and midnight pizza. In Cell Metabolism on September 24, Salk Institute scientists ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.